1. (a) An employee or agent of an institution of higher education must complete an anaphylaxis training program before providing or administering an epinephrine autoinjector or intranasal epinephrine spray made available by an institution of higher education. The training must be conducted by a nationally-recognized organization experienced in training laypersons in emergency health treatment or an entity or individual approved by the Department. Training may be conducted online or in person and, at a minimum, must cover all of the following:

   1. (1) Techniques on how to recognize symptoms of severe allergic reactions, including anaphylaxis.
   2. (2) Standards and procedures for the storage and administration of an epinephrine autoinjector and intranasal epinephrine spray.
   3. (3) Risks of administering an epinephrine autoinjector or intranasal epinephrine spray that has expired or that was not stored at the proper temperature.
   4. (4) Potential contraindications, risks, side effects, or medication reactions after appropriate use.
   5. (5) The differences in usage, storage, and administration of EpiPen Jr. autoinjectors and intranasal epinephrine sprays.
   6. (6) What to do if an individual is at a borderline weight.
   7. (7) Emergency follow-up procedures.
2. (b) The entity that conducts the training shall issue a certificate, on a form developed or approved by the Department, to each person who successfully completes the anaphylaxis training program.
3. (c) An individual who successfully completes an anaphylaxis training under this section may use epinephrine autoinjectors and intranasal epinephrine sprays prescribed under § 3013E of this title for 2 years from the date of completion on the certificate issued under subsection (b) of this section.

83 Del. Laws, c. 122, § 3; 85 Del. Laws, c. 410, § 1